Rigorous clinical research expertise, regulatory intelligence, and fractional executive leadership — from first-in-human to market access.
Angela M L dos Santos is the founder and principal consultant of Aegis Clinical Strategies — a UK-based sole trader consultancy delivering specialist clinical research and regulatory strategy to the global MedTech sector.
With a decade of hands-on experience spanning clinical trial design, protocol development, clinical evaluation, and the integration of clinical strategy into product development, Angela has guided MedTech innovators through complex regulatory landscapes including EU MDR, UKCA, and FDA submissions.
Her career trajectory — from Lead Physiologist at King’s College Hospital to Clinical Research Scientist at Nevro and Director of Global Clinical Research at Nyxoah — reflects a rare combination of bench-level scientific rigour, GCP-compliant trial execution, and C-suite strategic leadership. Advanced qualifications in Clinical Research (MSc, University of Liverpool), Psychological Sciences (MSc, Brunel), PgCert in Clinical Education (King’s College London), and a DBA in progress at ESGCI Paris underpin a uniquely multi-disciplinary perspective.
The global MedTech market is expanding rapidly, driven by increasingly stringent regulatory frameworks that demand robust, independently-verified clinical evidence.
From early feasibility through post-market surveillance, Aegis provides the clinical and regulatory infrastructure your programme requires — at the pace your milestones demand.
Ready to build a clinical strategy that accelerates your regulatory pathway?
Request a Scoping CallWhether you are navigating a first regulatory submission, designing a pivotal trial, or seeking embedded clinical leadership, Aegis Clinical Strategies provides the independent expertise to advance your programme with confidence.